FDA Relents, Approves Novel Antidepressant After Many Rejections

(MedPage Today) -- After multiple prior rejections, gepirone hydrochloride extended-release (ER; Exxua) gained FDA approval for the treatment of major depressive disorder (MDD) in adults, drugmaker Fabre-Kramer Pharmaceuticals announced. Gepirone...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news
More News: Depression | Psychiatry